Sterna Biologicals holds Scientific Advisory Board meeting at 14th Congress of ECCO to advance phase IIb clinical development program of SB012 in Ulcerative Colitis

DGAPNews sterna biologicals GmbH & Co. KG Key words Miscellaneous18.03.2019 1400 The issuer is solely responsible for the content of this announcement.STERNA BIOLOGICALS HOLDS SCIENTIFIC ADVISORY BOARD MEETING AT 14th CONGRESS OF ECCO TO ADVANCE PHAS...